GionM., MioneR., DattadiR., FasanS., PallinA., Brusca-gninG.Evaluation of CA 15.3 serum levels in breast cancer patients.J Nucl Med All Sci1986; 30: 1–8.
2.
ColomerR., RuibalA., NavarroM.. Circulating CA 15.3 levels in breast cancer. Our present experience.Int J Biol Markers (In press).
3.
RuibalA., GuargaA., UrrutiaA., GrisJ.M.Comportamiento del CA 15.3 sérico en pacientes afectos de patolo-gías no tumorales. Resultados preliminares.Med Clin1986; 86: 262.
4.
RuibalA., EncaboG., GenolláV., GuargaA., UrrutiaA., ColomerR.Serum CA 15.3 levels in patients with general pathology and malignant diseases (excluding breast cancer).Bull Cancer (Paris)1986; 73: 94–95.
